AWS Seed successfully completed
Today we are happily announcing the successful completion of the AWS Seed financing phase. Since the start in 11.04.2016 and over the last three years of our fruitful cooperation, the …
Cutaneous T-Cell Lymphoma clinical study using Scarletred®Vision
PIQUR Therapeutics has kicked off the first human topical application of bimiralisib for patients with the rare disease “Cutaneous T-Cell Lymphoma”. The local tolerability of bimiralisib will be evaluated using …
ISO 13485 certificate
We are aiming to supply the highest product and service quality to our clients. ISO 13485 specifies the requirements for a quality management (QM) system where an organization needs to …
Patents granted in Japan and Australia
After having already obtained patent approval for product Scarletred®Vision in EU and USA we can now positively report that IP protection could be expanded also to Japan and Australia. Our …
Meet our new PR & Marketing Manager Marije Kruis
Marije Kruis joined the SCARLETRED team as a new PR & Marketing Manager as of this month. We already got introduced to Marije back in 2016 when SCARLETRED was the …
Scarletred®Vision, Hidradenitis Suppurativa
HIDRADENITIS SUPPURATIVA DISEASE ACTIVITY Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease affecting up to 2% of European adults. Disease activity is commonly assessed by counting of inflammatory nodules, …
Scarletred®Vision, 128 Shades of Red
128 SHADES OF RED Abstract The purpose of our investigation was to develop a novel and state of the art digital skin imaging method capable for remote monitoring and objective …
Scarletred schlägt Immobilien-Projekte
HEALTHTECH-STARTUP SCARLETRED SCHLÄGT IMMOBILIEN-PROJEKTE Nicht-Immobilien-Projekt im Oktober auf Platz 1 Auch wenn Immobilien-Projekte im Oktober mit mehr als 76% der Gesamtzuflüsse den Markt klar dominierten, ist das zuflussstärkste Projekt des …
Tagesspiegel, “Future Medicine 2018” in Berlin
SCARLETRED – FUTURE MEDICINE, BERLIN Zu den Zukunftsentwicklungen, die bereits Realität sind, gehören Anwendungen wie die des österreichischen Start-ups „Scarletred“. Per Mobiltelefon, kostenloser App und kostenpflichtigem Diagnosepflaster lassen sich laut …
SCARLETRED – OE24.TV FRÜHSTÜCKSTALK
SCARLETRED – OE24.tv Frühstückstalk CEO Harald Schnidar im FRÜHSTÜCKS-TALK bei Oe24.tv über SCARLETRED, die breite Anwendung von SCARLETRED®VISION, unsere aktuelle Crowd Kampagne mit GREEN ROCKET und die weiteren Schritte 2019 …